-
1دورية أكاديمية
المؤلفون: Kansy, Benjamin A., Wehrs, Tim P., Bruderek, Kirsten, Si, YuAff1, Aff9, Ludwig, Sonja, Droege, Freya, Hasskamp, Pia, Henkel, Uta, Dominas, Nina, Hoffmann, Thomas K., Horn, Peter A., Schuler, MartinAff5, Aff6, Gauler, Thomas C.Aff5, Aff7, Lindemann, Monika, Lang, StephanAff1, Aff6, Bankfalvi, Agnes, Brandau, SvenAff1, Aff6, IDs00262023035718_cor17
المصدر: Cancer Immunology, Immunotherapy. 72(12):4367-4383
-
2دورية أكاديمية
المؤلفون: Hoffmann Thomas K, Greve Jens, Schuler Patrick J, Wild Clarissa A, Pütter Carolin, Lotfi Ramin, Bankfalvi Agnes, Bachmann Hagen S, Bergmann Christoph, Lang Stephan, Scherag André, Lehnerdt Götz F
المصدر: Journal of Translational Medicine, Vol 9, Iss 1, p 139 (2011)
مصطلحات موضوعية: Toll-like receptor 4, Single-nucleotide polymorphism, HNSCC, Medicine
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Hegedüs, Luca, Okumus, Özlem, Mairinger, Fabian, Ploenes, Till, Reuter, Sebastian, Schuler, Martin, Welt, Anja, Vega-Rubin-de-Celis, Silvia, Theegarten, Dirk, Bankfalvi, Agnes, Aigner, Clemens, Hegedüs, Balazs
المصدر: In Lung Cancer April 2023 178:237-246
-
4دورية أكاديمية
المؤلفون: Guberina, MajaAff1, Sak, Ali, Pöttgen, Christoph, Tinhofer-Keilholz, IngeborgAff2, Aff3, Budach, VolkerAff2, Aff3, Balermpas, PanagiotisAff4, Aff5, Von der Grün, JensAff4, Aff5, Rödel, Claus MichaelAff4, Aff5, Gkika, Eleni, Grosu, Anca-LigiaAff6, Aff7, Abdollahi, AmirAff8, Aff9, Aff10, Aff11, Aff12, Debus, JürgenAff8, Aff9, Aff10, Aff12, Aff13, Belka, ClausAff14, Aff15, Aff16, Pigorsch, SteffiAff14, Aff17, Combs, Stephani E.Aff14, Aff17, Aff18, Mönnich, DavidAff19, Aff20, Zips, DanielAff19, Aff20, De-Colle, Chiara, Welz, Stefan, Linge, AnnettAff21, Aff22, Aff23, Aff24, Aff25, Lohaus, FabianAff21, Aff22, Aff23, Aff24, Aff25, Baretton, GustavoAff23, Aff24, Aff25, Aff26, Aff27, Gauler, Thomas, Baumann, MichaelAff21, Aff22, Aff25, Aff27, Krause, MechthildAff11, Aff21, Aff22, Aff23, Aff24, Aff25, Aff27, Schuler, MartinAff28, Aff29, Aff30, Bankfalvi, Agnes, Höing, Benedikt, Lang, Stephan, Stuschke, MartinAff1, Aff28
المصدر: The Pharmacogenomics Journal. 21(1):37-46
-
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Hegedűs, Luca, Rittler, Dominika, Garay, TamásAff2, Aff3, Stockhammer, PaulAff1, Aff4, Kovács, Ildikó, Döme, BalázsAff4, Aff5, Aff6, Theurer, Sarah, Hager, Thomas, Herold, Thomas, Kalbourtzis, Stavros, Bankfalvi, Agnes, Schmid, Kurt W., Führer, Dagmar, Aigner, Clemens, Hegedűs, BalázsAff1, Aff2
المصدر: Pathology & Oncology Research: Official Journal of the Arányi Lajos Foundation. 26(4):2523-2535
-
7دورية أكاديمية
المؤلفون: Kansy, Benjamin A., Wehrs, Tim P., Bruderek, Kirsten, Si, Yu, Ludwig, Sonja, Droege, Freya, Hasskamp, Pia, Henkel, Uta, Dominas, Nina, Hoffmann, Thomas K., Horn, Peter A., Schuler, Martin, Gauler, Thomas C., Lindemann, Monika, Lang, Stephan, Bankfalvi, Agnes, Brandau, Sven
المصدر: Cancer Immunology, Immunotherapy; Dec2023, Vol. 72 Issue 12, p4367-4383, 17p
مصطلحات موضوعية: REGULATORY T cells, MYELOID-derived suppressor cells, T cells, IMMUNITY
-
8دورية أكاديمية
المؤلفون: Pfitzner, Berit M, Lederer, Bianca, Lindner, Judith, Solbach, Christine, Engels, Knut, Rezai, Mahdi, Dohnal, Karel, Tesch, Hans, Hansmann, Martin L, Salat, Christoph, Beer, Michaela, Schneeweiss, Andreas, Sinn, Peter, Bankfalvi, Agnes, Darb-Esfahani, Silvia, von Minckwitz, Gunter, Sinn, Bruno V, Kronenwett, Ralf, Weber, Karsten, Denkert, Carsten, Loibl, Sibylle
المصدر: In Modern Pathology April 2018 31(4):607-615
-
9دورية أكاديمية
المؤلفون: Borchert, SabrinaAff1, Aff2, Suckrau, Pia-Maria, Walter, Robert F. H.Aff1, Aff2, Aff5, Wessolly, MichaelAff1, Aff2, Mairinger, ElenaAff1, Aff2, Steinborn, JuliaAff1, Aff2, Hegedus, Balazs, Hager, ThomasAff1, Aff2, Herold, ThomasAff1, Aff2, Eberhardt, Wilfried E. E.Aff4, Aff5, Wohlschlaeger, JeremiasAff1, Aff6, Aigner, Clemens, Bankfalvi, AgnesAff1, Aff2, Schmid, Kurt WernerAff1, Aff2, Mairinger, Fabian D.Aff1, Aff2
المصدر: Scientific Reports. 10(1)
-
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.